- Home
- NLSP vs FTEL Comparison
NLSP vs FTEL Comparison
Compare NLSP & FTEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NLSP
- FTEL
- Stock Information
- Founded
- NLSP 2015
- FTEL 2007
- Country
- NLSP Switzerland
- FTEL Australia
- Employees
- NLSP N/A
- FTEL N/A
- Industry
- NLSP Biotechnology: Pharmaceutical Preparations
- FTEL
- Sector
- NLSP Health Care
- FTEL
- Exchange
- NLSP Nasdaq
- FTEL Nasdaq
- Market Cap
- NLSP 12.4M
- FTEL 11.1M
- IPO Year
- NLSP 2021
- FTEL 2023
- Fundamental
- Price
- NLSP $2.13
- FTEL $0.70
- Analyst Decision
- NLSP
- FTEL
- Analyst Count
- NLSP 0
- FTEL 0
- Target Price
- NLSP N/A
- FTEL N/A
- AVG Volume (30 Days)
- NLSP 268.4K
- FTEL 211.9K
- Earning Date
- NLSP 07-22-2025
- FTEL 07-22-2025
- Dividend Yield
- NLSP N/A
- FTEL N/A
- EPS Growth
- NLSP N/A
- FTEL N/A
- EPS
- NLSP N/A
- FTEL N/A
- Revenue
- NLSP N/A
- FTEL $4,990,695.00
- Revenue This Year
- NLSP N/A
- FTEL N/A
- Revenue Next Year
- NLSP N/A
- FTEL N/A
- P/E Ratio
- NLSP N/A
- FTEL N/A
- Revenue Growth
- NLSP N/A
- FTEL 29.02
- 52 Week Low
- NLSP $1.30
- FTEL $0.36
- 52 Week High
- NLSP $15.59
- FTEL $49.50
- Technical
- Relative Strength Index (RSI)
- NLSP 43.58
- FTEL 66.21
- Support Level
- NLSP $2.20
- FTEL $0.47
- Resistance Level
- NLSP $2.33
- FTEL $0.52
- Average True Range (ATR)
- NLSP 0.25
- FTEL 0.06
- MACD
- NLSP -0.07
- FTEL 0.03
- Stochastic Oscillator
- NLSP 6.86
- FTEL 76.79
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.
About FTEL Fitell Corporation
Fitell Corp engages in primary operations of selling gym and fitness equipment in Australia through its indirectly held wholly owned subsidiaries. It operates in two segments: online fitness equipment distribution and licensing business to service the large and growing boutique fitness sector of the broader health and fitness club industry. The majority fitness equipment business is conducted in Australia via its own e-commerce platform and, through third-party sites. Licensing service offers a turnkey solution for personal training studios and commercial gym chains. The company earns maximum of revenue for retail.